Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 11/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23805924 | 0.89 | PDK2 (0.37) | PDK2MEN1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL23805905 | 0.83 | PDK2 (0.43) | PDK2THRATHRB | |
| SCHEMBL23805892 | 0.82 | PDK2 (0.35) | PDK2MEN1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL23805882 | 0.80 | PDK2 (0.40) | PDK2MEN1KMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL20099323 | 0.78 | SMN1; SMN2 (0.40) | PDK2MEN1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL21024768 | 0.77 | PDK2 (0.40) | PDK2CYP3A4CNR2 | |
| SCHEMBL21025023 | 0.75 | PDK2 (0.45) | PDK2 | |
| SCHEMBL22462068 | 0.75 | PDK2 (0.45) | PDK2 | |
| SCHEMBL23805893 | 0.74 | PDK2 (0.43) | PDK2 | |
| SCHEMBL28944088 | 0.74 | RARB (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | TRPA1, TYR, PKLR | PDK2 58/4885MEN1 3544/4885CYP3A4 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.